New test that can detect deadly illness could be available in the next year, scientist claim
“While we still need to confirm these findings in a larger study, we’re hopeful that it won’t be long until this blood test is in regular use," she said.
Myocarditis is a difficult condition to diagnose as symptoms are often mistaken for other conditions. he main symptoms to look out for, according to the British Heart Foundation and the Mayo Clinic, are:flu-like symptoms such as a high temperature, tiredness and fatigue shortness of breath when lightly exercising or walking a sudden shortness of breath - if you experience this get urgent medical help The MHRA said anyone who experiences "chest pain, shortness of breath or feelings of having a fast-beating, fluttering, or pounding heart" after a jab should seek urgent medical attention.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
The Walking Dead's Maggie and Negan return in first teaser for Dead City spinoffThe pair are facing new threats in New York.
Læs mere »
Kate Middleton adds a very important brooch to her signature outfit formulaKateMiddleton follows in PrincessDiana's footsteps with this historic brooch.
Læs mere »
Inside the disused pub due to reopen after four years with new owners and new nameThese photos show the rundown interior of a pub that's set to soon be given a makeover and reopened to customers.
Læs mere »
'I'm not the Grinch': RMT union boss Mick Lynch defends new Christmas and New Year strikesMore walkouts are planned on the trains - this time over the festive period - as two weeks of talks fail to produce a deal.
Læs mere »
New York sewer rats are easily infected by SARS-CoV-2, according to new studyNew York sewer rats are easily infected by SARS-CoV-2, according to new study biorxivpreprint Mizzou NewYork USA Rats Infection SARSCoV2 Variant COVID19
Læs mere »
Target product profiles for novel medicines to prevent and treat preeclampsia: An expert consensusBackground Preeclampsia and eclampsia are a leading cause of global maternal and newborn mortality. Currently, there are few effective medicines that can prevent or treat preeclampsia. Target Product Profiles (TPPs) are important tools for driving new product development by specifying upfront the characteristics that new products should take. Considering the lack of investment and innovation around new medicines for obstetric conditions, we aimed to develop two new TPPs for medicines to prevent and treat preeclampsia. Methods and findings We used a multi-methods approach comprised of a literature review, stakeholder interviews, online survey, and public consultation. Following an initial literature review, diverse stakeholders (clinical practice, research, academia, international organizations, funders, consumer representatives) were invited for in-depth interviews and an online international survey, as well as public consultation on draft TPPs. The level of stakeholder agreement with TPPs was assessed, and findings from interviews were synthesised to inform the final TPPs. We performed 23 stakeholder interviews and received 46 survey responses. A high level of agreement was observed in survey results, with 89% of TPP variables reaching consensus (75% agree or strongly agree). Points of discussion were raised around the target population for preeclampsia prevention and treatment, as well as the acceptability of cold-chain storage and routes of administration. Conclusion There is consensus within the maternal health research community on the parameters that new medicines for preeclampsia prevention and treatment must achieve to meet real-world health needs. These TPPs provide necessary guidance to spur interest, innovation and investment in the development of new medicines to prevent and treat preeclampsia.
Læs mere »